Benitec Biopharma Inc. Common Stock (BNTC) is a publicly traded Healthcare sector company. As of November 13, 2026, BNTC trades at $9.15 with a market cap of $330.40M and a P/E ratio of -9.05. BNTC moved +0.00% today. Year to date, BNTC is -23.13%; over the trailing twelve months it is -31.99%. Its 52-week range spans $7.89 to $17.15. Analyst consensus is strong buy with an average price target of $22.00. Rallies surfaces BNTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BNTC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $9.15 |
| Market Cap | $330.40M |
| P/E Ratio | -9.05 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.15 |
| 52-Week Low | $7.89 |
| Volume | 2.40K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-45.55M |
| Gross Margin | 0.00% |
5 analysts cover BNTC: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.00.